(Q54058828)
Statements
A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. (English)
J M Cunningham
H Blaszyk
A Hartmann
D Schaid
L E Wold
J S Kovach
S S Sommer
1 January 2000
89
1
32-38